Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced Thursday it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals, a strategic deal that expands Biofourmis’ portfolio in the oncology space. Gaido Health – a Los Angeles-area based digital therapeutics company focused on the oncology market – was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. The acquisition seeks to address a disconnected oncology care pathway that has led to more than 30% of patients on chemotherapy being readmitted to the hospital or requiring a visit to the emergency department.

Read the full article: Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health //

Source: https://www.prnewswire.com/news-releases/digital-therapeutics-leader-biofourmis-expands-into-oncology-market-with-strategic-acquisition-of-gaido-health-301041721.html

Scroll to Top